Fundraising Fox

Venture Capital Investment Management

Venture capital

San Francisco · 7 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

The firm applies Disruption Theory to identify early-stage healthcare companies entering markets at lower cost tiers or non-mainstream segments, rather than competing directly with incumbents. Healthcare disruptors like Genentech, Invisalign, 23andMe, AthenaHealth, and ZocDoc exemplify this approach. The firm uses proprietary technology called MESE® to analyze hundreds of early-stage candidates daily and identify top-performing companies using custom data analytics, enabling both proactive outbound deal sourcing and inbound network development. This disciplined strategy aims to find young companies at lower valuations that can deliver traditional venture capital returns in a healthcare industry experiencing significant disruption from shifting gatekeepers toward consumers and self-insured corporations.

Invests inHealthtechSector AgnosticSan Francisco

Source: firm website, verified Jul 21, 2026.

HQ
San Francisco, US
Founded
1972
Tracked investments
26

Team · 7 people

from the firm's website
Bill Hambrecht· Partner

Partner at Hambrecht Ventures, founder of WR Hambrecht+Co, and co-founder of Hambrecht & Quist. He has overseen nearly 700 company investments including early-stage funding and IPO transactions for Apple, Amazon, Adobe, Genentech, Google, Intel, Nvidia, Pixar, and Salesforce. He serves on the boards of Buoy Health and PatientsLikeMe.

Elizabeth Hambrecht· Managing Partner

Managing Partner at Hambrecht Ventures who has collaborated with her father Bill Hambrecht for over a decade. She previously served as CEO of Salon Media, co-founded Asiacontent.com, and worked as an equities analyst at Goldman Sachs covering emerging markets. She sits on the boards of Tasso Inc., Proov, and Golden.

Thomas Thurston· Partner

Partner at Hambrecht Ventures since 2008 and data scientist who created the MESE computing system. He leads an eight-person data science team providing market and private business insights. Previously at Intel, he helped found a high-performance computing business and led a joint research program with Harvard Business School on applying data science to venture capital.

Gene Yates· Chief Financial Officer

Chief Financial Officer of WR Hambrecht + Co since 2014 with over 25 years of senior finance experience in financial services. Previously served as CFO at Wells Fargo Securities and held controller and regulatory roles at Charles Schwab. Holds a BS in Accounting & Finance from USC.

John Hullar· Advisory Role

Served as Managing Partner at WRH+Co from 2013 to 2018. Held executive positions including President and CEO at Wells Fargo Securities and Managing Director of the Western Region. Previously led institutional sales and brokerage operations at Morgan Stanley and H&Q. Holds a B.A. in Economics and Political Science from Yale University.

Lee Ting· Advisory Role

Retired Hewlett Packard executive with over 31 years of experience, most recently as Corporate Vice President managing operations across 120+ countries. Since 2001 has been a Partner at Hambrecht Ventures Funds 1 and 2 focusing on early-stage technology and bioscience investments in the US and China. Serves on multiple boards and holds a BS in Electrical Engineering from Oregon State University.

Veronica Bryan· Partner, Operations and Human Resources

Has held HR and operations positions at WR Hambrecht + Co since 1999, supporting both Hambrecht Capital and Hambrecht Ventures as well as portfolio companies. Previously served as AVP at Bank of America.

Investments · 26 tracked

founders shown can be your intro path
ACTIVE
AeroFarms
Amuse
Arcimoto
Burt's Bees
Calithera Biosciences
Cardiometrix
Color Genomics
Elevate
Fintech platform in China
GoodRx
Jounce Therapeutics
K Health
Medidata
Mindstrong
Mothership
Neurotrack
Ombre
Ōn
Ro
Salesforce
SurveySampling International
Tango
Tasso
TeamViewer
Toms of Maine

Frequently asked questions

What sectors does Venture Capital Investment Management focus on?
Venture Capital Investment Management focuses on Healthtech, Sector Agnostic.
Where is Venture Capital Investment Management located?
Venture Capital Investment Management is headquartered in San Francisco, US.

Similar investors

83North

83North is a lean venture capital partnership of four equal general partners that has operated for 19 years. The firm invests globally across the US, Europe, and Israel, and in 2025 raised what it describes as its final fund, shifting focus toward selectively pursuing new opportunities while supporting existing portfolio companies.

8VC

8VC is a technology investment firm focused on building and investing in ambitious companies across life sciences, healthcare, manufacturing, enterprise, logistics, and defense sectors, with particular emphasis on operational intelligence and data-driven decision-making.

Andreessen Horowitz

a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.

B Capital Group

B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.

Bessemer Venture Partners

Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.

Featured in lists